Pandora Wealth, Inc. Esperion Therapeutics, Inc. Transaction History
Pandora Wealth, Inc.
- $165 Billion
- Q3 2025
A detailed history of Pandora Wealth, Inc. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Pandora Wealth, Inc. holds 7,500 shares of ESPR stock, worth $21,750. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,500
Previous 7,500
-0.0%
Holding current value
$21,750
Previous $7.38 Million
169.2%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ESPR
# of Institutions
213Shares Held
113MCall Options Held
643KPut Options Held
769K-
Black Rock Inc. New York, NY14MShares$40.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$35.1 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.75MShares$28.3 Million0.51% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT7.06MShares$20.5 Million0.1% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.4 Million7.68% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $193M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...